A pancreatic sarcoma of nerve sheath origin is reported in a 28-year-old female patient, who presented with melaena. Preoperative imaging showed an 8.5 cm diameter mass in the head of pancreas. There was bleeding from the papilla of Vater at endoscopy and a highly vascular lesion on arteriography. The patient was submitted to proximal pancreatoduodenectomy and remains symptom-free at year followup.
INTRODUCTION
Pancreatic tumors of mesenchymal origin are extremely rare. Only a few cases have been reported, relating to different kinds of sarcoma, but full appraisal of the histological origin by immunohistochemical methods is scarce1-3. We therefore report a case of a pancreatic stromal tumour with nerve sheath differentiation.
CASE REPORT
The patient was a 29 year-old white female, whose main complaint was of tarry stools and anaemia. Upper gastrointestinal endoscopy revealed bleeding from the papilla of Vater. Ultrasonography showed a mass in the head of the pancreas, 8.5 cm in maximal diameter, of mixed echogenicity and compressing the inferior vena cava. Abdominal CT scan confirmed these findings (Figure 1 ). There was no dilatation of the biliary tract. Selective arteriography of the coeliac trunk and superior mesenteric artery identified a hypervascular lesion in the pancreatic region, fed mainly from the inferior pancreaticoduodenal artery (Figure 2 ).
At laparotomy there was a large mass in the head of the pancreas with a rich collateral circulation, but the tumour was still mobile. There was no evidence of dissemination. The bile duct appeared normal, as did the body and tail of pancreas. Proximal pancreatoduodenectomy was performed including partial gastrectomy. Macroscopic examination of the operative specimen ( Figure 3) To determine the origin of the tumour, an immunohistochemical study was performed. Deparaffinized sections were incubated with the following panel of monoclonal and/or polyclonal antibodies, localization was by means of the avidin biotin (ABC) immunoperoxidase method. The results were negative for low molecular weight cytokeratin (35BHll), high molecular weight cytokeratin (34BE12), epithelial membrane antigen, carcinoembryonic antigen, muscle actins (HHF35), desmin (Clone 33), melanoma specific antigen (HMB45), CD57(Leu-7), type IV collagen, nerve growth factor receptor protein (NGFR 5), neurofilament (2Fll,NRV170), myelin basic protein, CD45 (T200) and synaptophysin. The results were uniformly positive for vimentin (Dako) and variably positive for S100 protein. The final diagnosis was consistent with a stromal tumour of nerve sheath origin.
The postoperative course was uneventful. At the time of writing, one year later, the patient remains asymptomatic with no evidence of recurrence.
DISCUSSION
In a review of more recent literature on pancreatic tumours, Kloppel records cases of lymphangioma, leiomyosarcoma, haemangioendothelioma, rhabdomyosarcoma, myeloma, malignant fibrous histiocytoma and haemangiopericytoma. In this case conventional hystological studies only could identify a spindle-cell sarcoma. The evidence that we were dealing with a stromal tumor of nerve sheath origin came later through immunochemical studies using several different antibodies.
It is important to note that the prognosis of such lesions, when they are removed, is much better than it is for tumours of epithelial origin. Although Professor Pereira-Lima and his colleagues call this a case of "pancreatic stromal tumour with nerve sheath differentiation", a less confusing term might be "malignant schwannoma of the pancreas". Malignant schwannomas are often multiple, affecting the limbs of patients with neurofibromatosis1, but they have been described in the stomach and duodenum and twice before in the pancreas2'3.
In the present case, positive categorisation as a mesenchymal tumour of nerve sheath origin rests on the presence of spindle cells, uniformly positive staining for vimentin (a mesenchymal marker) and variably positive staining for S100 protein (a nerve sheath marker). Markers were negative for epithelial cells, smooth muscle, striated muscle and nerve cells, together with melanoma specific antigen. The authors have provided no details of the tissue preparation for immunohistochemistry, yet the method and duration of fixation can affect interpretation of the results. For example, desmin and neurofilaments may not be labelled by monoclonal antibodies after 24 hours of formaldehyde fixation, and trypsinisation impairs the staining for cytokeratins4. Moreover, vimentin is positive not only in mesenchymal tumours but also in papillary-cystic neoplasm (solid and cystic tumour) of the pancreas and in nearly all amelanotic melanomas6. Likewise, S100 protein is positive in all amelanotic melanomas 6 and one third of papillary-cystic neoplasms5. The lack of electronmicroscopic examination of this tumour does weaken the diagnosis of malignant schwannoma, since light-microscopic criteria can be inadequate7. Characteristic ultrastructural features of malignant schwannoma include the demonstration of basement membranes, functional complexes and interdigitating cytoplasmic extensions containing dense neurosecretory-like granules and axon-like structures3 '7. The cystic centre of the tumour on scanning, its marked vascularity and-to a lesser extent the young age of the patient made "ordinary" ductal carcinoma of the pancreas unlikely in this case. The preoperative differential diagnosis might therefore have included non-functioning endocrine tumour (which can be cystic), cystadenocarcinoma and papillary-cystic neoplasm, although the subsequent pathological findings helped to exclude these alternatives. The cystic nature and extreme vascularity of pancreatic schwannoma were features of the two previous case reports, one of which presented as a pulsatile mass and was initially drained into the stomach as an apparent pseudocyst2. This experience reinforces the need to biopsy the wall of all "pseudocysts''8. We agree with the authors that resectable tumours of the pancreas should be resected even without a precise preoperative diagnosis and that pancreatoduodenectomy is indicated for lesions in the head of the gland.
